Ligand id: 9778

Name: cusatuzumab

Bioactivity Comments
ARGX-110 blocks CD70-CD27 signaling, and exhibits potent complement-dependent cytotoxicity and antibody-dependent cellular phagocytosis activity [2]. Blocking CD70 activation of CD27 blocks the activation and proliferation of Treg cells, and triggers T cell-mediated tumour cell destruction. Its half-life is 12 days in cynomolgus monkeys [2].
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD70 Hs Antibody Binding 10.7 pKd - 1
pKd 10.7 (Kd 1.9x10-11 M) [1]
Description: Equilibrium dissociation constant determined by surface plasmon resonance analysis using a hCD70-coated sensor chip.